BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 21592112)

  • 1. The role of indoleamine 2, 3-dioxygenase in lepromatous leprosy immunosuppression.
    de Souza Sales J; Lara FA; Amadeu TP; de Oliveira Fulco T; da Costa Nery JA; Sampaio EP; Pinheiro RO; Sarno EN
    Clin Exp Immunol; 2011 Aug; 165(2):251-63. PubMed ID: 21592112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterium leprae induces a tolerogenic profile in monocyte-derived dendritic cells via TLR2 induction of IDO.
    Oliveira JAP; Gandini M; Sales JS; Fujimori SK; Barbosa MGM; Frutuoso VS; Moraes MO; Sarno EN; Pessolani MCV; Pinheiro RO
    J Leukoc Biol; 2021 Jul; 110(1):167-176. PubMed ID: 33040382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell regulation in lepromatous leprosy.
    Bobosha K; Wilson L; van Meijgaarden KE; Bekele Y; Zewdie M; van der Ploeg-van Schip JJ; Abebe M; Hussein J; Khadge S; Neupane KD; Hagge DA; Jordanova ES; Aseffa A; Ottenhoff TH; Geluk A
    PLoS Negl Trop Dis; 2014 Apr; 8(4):e2773. PubMed ID: 24722473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
    Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
    Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD163 favors Mycobacterium leprae survival and persistence by promoting anti-inflammatory pathways in lepromatous macrophages.
    Moura DF; de Mattos KA; Amadeu TP; Andrade PR; Sales JS; Schmitz V; Nery JA; Pinheiro RO; Sarno EN
    Eur J Immunol; 2012 Nov; 42(11):2925-36. PubMed ID: 22851198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indoleamine 2,3-dioxygenase and iron are required for Mycobacterium leprae survival.
    de Mattos Barbosa MG; da Silva Prata RB; Andrade PR; Ferreira H; de Andrade Silva BJ; da Paixão de Oliveira JA; Assis TQ; de Toledo-Pinto TG; de Lima Bezerra OC; da Costa Nery JA; Rosa PS; Bozza MT; Lara FA; Moraes MO; Schmitz V; Sarno EN; Pinheiro RO
    Microbes Infect; 2017 Nov; 19(11):505-514. PubMed ID: 28684130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
    J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Mycobacterium leprae antigens from a cosmid library: characterization of a 15-kilodalton antigen that is recognized by both the humoral and cellular immune systems in leprosy patients.
    Sela S; Thole JE; Ottenhoff TH; Clark-Curtiss JE
    Infect Immun; 1991 Nov; 59(11):4117-24. PubMed ID: 1840579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
    Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human regulatory macrophages are potent in suppression of the xenoimmune response via indoleamine-2,3-dioxygenase-involved mechanism(s).
    Guo F; Hu M; Huang D; Zhao Y; Heng B; Guillemin G; Lim CK; Hawthorne WJ; Yi S
    Xenotransplantation; 2017 Sep; 24(5):. PubMed ID: 28771838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in TGF-β secreting CD4⁺CD25⁺ FOXP3⁺ T regulatory cells in anergic lepromatous leprosy patients.
    Saini C; Ramesh V; Nath I
    PLoS Negl Trop Dis; 2014; 8(1):e2639. PubMed ID: 24454972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B7-1, but not CD28, is crucial for the maintenance of the CD4+ T cell responses in human leprosy.
    Schlienger K; Uyemura K; Jullien D; Sieling PA; Rea TH; Linsley PS; Modlin RL
    J Immunol; 1998 Sep; 161(5):2407-13. PubMed ID: 9725237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation and cytokine profile of monocyte derived dendritic cells in leprosy: in vitro stimulation by sonicated Mycobacterium leprae induces decreased level of IL-12p70 in lepromatous leprosy.
    Braga AF; Moretto DF; Gigliotti P; Peruchi M; Vilani-Moreno FR; Campanelli AP; Latini AC; Iyer A; Das PK; Souza VN
    Mem Inst Oswaldo Cruz; 2015 Aug; 110(5):655-61. PubMed ID: 26222022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of transforming growth factor-beta 1 (TGF-beta1) by blood monocytes from patients with different clinical forms of leprosy.
    Goulart IM; Mineo JR; Foss NT
    Clin Exp Immunol; 2000 Dec; 122(3):330-4. PubMed ID: 11122237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Levels of Migration Inhibitory Factor (MIF) and
    Martinez-Guzman MA; Alvarado-Navarro A; Delgado-Rizo V; Garcia-Orozco A; Mayorga-Rodríguez JA; Pereira-Suarez AL; Fafutis-Morris M
    Front Immunol; 2018; 9():246. PubMed ID: 29487601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced suppressor cell response to Mycobacterium leprae in lepromatous leprosy.
    Sasiain MD; de la Barrera S; Valdez R; Balina LM
    Infect Immun; 1989 Mar; 57(3):951-6. PubMed ID: 2521841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for CD40-CD40 ligand interactions in the generation of type 1 cytokine responses in human leprosy.
    Yamauchi PS; Bleharski JR; Uyemura K; Kim J; Sieling PA; Miller A; Brightbill H; Schlienger K; Rea TH; Modlin RL
    J Immunol; 2000 Aug; 165(3):1506-12. PubMed ID: 10903757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accessory cell heterogeneity in lepromatous leprosy; dendritic cells and not monocytes support T cell responses.
    Mittal A; Mishra RS; Nath I
    Clin Exp Immunol; 1989 May; 76(2):233-9. PubMed ID: 2503276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular immune response to Mycobacterium leprae infection in human immunodeficiency virus-infected individuals.
    Sampaio EP; Caneshi JR; Nery JA; Duppre NC; Pereira GM; Vieira LM; Moreira AL; Kaplan G; Sarno EN
    Infect Immun; 1995 May; 63(5):1848-54. PubMed ID: 7729894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.